chartexchange

BYSI
BeyondSpring Inc.
stockNASDAQ

At CloseNov 13, 2026 11:52:41 AM EST
0.61USD+1.913%(+0.01)33,174
After-hoursNov 13, 2026 4:00:30 PM EST
0.6012USD-1.845%(-0.0113)
Loading…
Loading…
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$0.60
Beta
0.74
52-Week High
$2.44 2025-12-12
52-Week Low
$0.42 2026-10-22
SMA 50
$0.66
SMA 200
$1.23
Avg. Vol 10D
248,510
Avg. Vol 30D
118,468
Avg. Vol 90D
643,791
Relative Vol
0.28
31.95M
6.9800%
2,200,000
BYSI Profile

beyondspring pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies. we are currently advancing the development of our lead asset plinabulin, a novel cancer therapeutic, in a global phase 3 trial in non-small-cell lung cancer (nsclc) and initiating a pivotal global phase 3 trial in prevention of docetaxel-induced neutropenia. as a tubulin depolymerizing agent, plinabulin works via multiple mechanisms of action to target and alter the tumor microenvironment: 1. immune enhancing effects via dendritic cell maturation 2. tumor cell apoptosis via activation of ras-jnk pathway 3. vascular disruptive effects given plinabulin's potential as a tumor micro-environment targeting agent, we intend to initiate clinical trials in additional cancer indications: • immuno-oncology, with immune checkpoint inhibitors in nsclc • cns malignancies including glioblastoma (gbm) • kras positive mutant cancers

BYSI Performance
PeriodPriceDateChangeBeta
1W0.632026-11-06-2.72%3.337
1M0.612026-10-13+0.38%0.667
3M1.002026-08-13-38.87%-0.076
6M1.452026-05-13-58.00%0.455
1Y2.062025-11-13-70.44%0.737
2Y1.852024-11-13-67.08%—
5Y14.802021-11-12-95.89%0.813
BYSI Stock Summary

BeyondSpring Inc. (NASDAQ:BYSI) stock price today is $0.61, and today's volume is 33,174. BYSI is up 1.331% today. The 30 day average volume is 118,468. BYSI market cap is $25.04M with 41.12M shares outstanding.